From NAFLD to MASLD: When metabolic comorbidity matters

CONCLUSIONS: The new nomenclature of MASLD and SLD is more applicable to identifying significant fibrosis than NAFLD. Patients with three or more cardiometabolic risk factors are at higher risk of fibrosis.PMID:38135250 | DOI:10.1016/j.aohep.2023.101281

Source: Annals of Hepatology - December 22, 2023 Category: Gastroenterology Authors: Shan Hong Lei Sun Yiwei Hao Ping Li Yuling Zhou Xiuxia Liang Julong Hu Hongshan Wei Source Type: research